These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 2382107)
1. Ciclosporin-induced immunosuppression in vitro. II. Variation in sensitivity and binding capacity. Povlsen JV; Rasmussen A; Madsen M; Lamm LU Scand J Immunol; 1990 Jul; 32(1):45-51. PubMed ID: 2382107 [TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A mediated immunosuppression in vitro: effect on high affinity interleukin-2 receptor expression and -turnover. Povlsen JV; Møller BK; Christiansen BS; Petersen CM Tissue Antigens; 1989 Jan; 33(1):4-14. PubMed ID: 2785298 [TBL] [Abstract][Full Text] [Related]
3. Mixed lymphocyte reaction-induced release of soluble IL-2 receptor. Degiannis D; Czarnecki M; Hornung N; Raskova J; Raska K Transplantation; 1991 Feb; 51(2):518-23. PubMed ID: 1825248 [TBL] [Abstract][Full Text] [Related]
4. The influence of FK-506 and low-concentration ciclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis. Woo J; Sewell HF; Thomson AW Scand J Immunol; 1990 Mar; 31(3):297-304. PubMed ID: 1690915 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of immunosuppressive effects of cyclosporin A by 1 alpha,25-dihydroxyvitamin D3. Gupta S; Fass D; Shimizu M; Vayuvegula B Cell Immunol; 1989 Jul; 121(2):290-7. PubMed ID: 2786759 [TBL] [Abstract][Full Text] [Related]
6. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine. Hess AD; Bright EC Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506 [TBL] [Abstract][Full Text] [Related]
7. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A. Foxwell BM; Simon J; Herrero JJ; Taylor D; Woerly G; Cantrell D; Ryffel B Immunology; 1990 Jan; 69(1):104-9. PubMed ID: 2312149 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of cyclosporins A and G on functional activation of a T-helper-lymphocyte line mediating experimental autoimmune uveoretinitis. Caspi RR; McAllister CG; Gery I; Nussenblatt RB Cell Immunol; 1988 May; 113(2):350-60. PubMed ID: 2965988 [TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients. Yoshimura N; Kahan BD Transplantation; 1985 Dec; 40(6):661-6. PubMed ID: 3934806 [TBL] [Abstract][Full Text] [Related]
10. Failure of prolyl-peptidyl isomerase to mediate cyclosporine suppression of intracellular activation signal generation. Kimball PM; Kerman RH; Kahan BD Transplantation; 1991 Feb; 51(2):509-13. PubMed ID: 1994547 [TBL] [Abstract][Full Text] [Related]
11. Binding of cyclosporine by human lymphocytes and phospholipid vesicles. LeGrue SJ; Friedman AW; Kahan BD J Immunol; 1983 Aug; 131(2):712-8. PubMed ID: 6863928 [TBL] [Abstract][Full Text] [Related]
12. Mediation of the antiproliferative effect of cyclosporine on human lymphocytes by blockade of interleukin 2 biosynthesis. Kermani-Arab V; Salehmoghaddam S; Danovitch G; Hirji K; Rezai A Transplantation; 1985 Apr; 39(4):439-42. PubMed ID: 3920796 [TBL] [Abstract][Full Text] [Related]
13. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin. Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143 [TBL] [Abstract][Full Text] [Related]
14. Effects of cyclosporin A on IL-2 production and lymphocyte proliferation during infection of mice with lymphocytic choriomeningitis virus. Kasaian MT; Biron CA J Immunol; 1990 Jan; 144(1):299-306. PubMed ID: 1967265 [TBL] [Abstract][Full Text] [Related]
15. Inter- and intra-subject variation of the suppression of mitogen-induced proliferation of human lymphocytes by cyclosporin-A: reduction of response with delayed addition may be relevant to timing of therapy. Spiers EM; Beck JS Int J Immunopharmacol; 1991; 13(2-3):245-50. PubMed ID: 2071297 [TBL] [Abstract][Full Text] [Related]
16. Molecular basis of Trypanosoma cruzi-induced immunosuppression. Altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle. Kierszenbaum F; Moretti E; Sztein MB Biol Res; 1993; 26(1-2):197-207. PubMed ID: 7670532 [TBL] [Abstract][Full Text] [Related]
17. Effect of interleukin 2 on the immunosuppressive action of cyclosporine. Hess AD Transplantation; 1985 Jan; 39(1):62-8. PubMed ID: 3155579 [TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A does not inhibit the PHA-stimulated increase in intracellular Ca2+ concentration but inhibits the increase in E-rosette receptor (CD2) expression and appearance of interleukin-2 receptors (CD25). Redelman D Cytometry; 1988 Mar; 9(2):156-63. PubMed ID: 2896111 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of immunosuppression by cyclosporins. Zenke G; Baumann G; Wenger R; Hiestand P; Quesniaux V; Andersen E; Schreier MH Ann N Y Acad Sci; 1993 Jun; 685():330-5. PubMed ID: 7689806 [TBL] [Abstract][Full Text] [Related]
20. Demonstration of a direct inhibitory effect of cyclosporine on normal human T-cells with two novel models of T-cell activation as probes. Sehajpal P; Subramaniam A; Murthi VK; Sharma VK; Suthanthiran M Cell Immunol; 1989 Apr; 120(1):195-204. PubMed ID: 2522829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]